VEGFR-1 mediates endothelial differentiation and formation of blood vessels in a murine model of infantile hemangioma

American Journal of Pathology

Volumn 179, Issue 5, 2011, Pages 2266-2277

  Boscolo, Elisa ^a   Mulliken, John B ^a   Bischoff, Joyce ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROPILIN 1; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADIPOCYTE; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY HEMANGIOMA; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LIFE CYCLE; MOUSE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; STEM CELL;

ANIMALS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; ENDOTHELIAL CELLS; ENZYME INHIBITORS; HEMANGIOMA; HUMANS; INFANT; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, NUDE; MICROVESSELS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; NEUROPILIN-1; PHOSPHORYLATION; SKIN NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR B; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 80054969284     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.07.040     Document Type: Article

References (43)

1. G.H. Fong, J. Rossant, M. Gertsenstein, and M.L. Breitman Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium Nature 376 1995 66 70
2. S. Hiratsuka, Y. Maru, A. Okada, M. Seiki, T. Noda, and M. Shibuya Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis Cancer Res 61 2001 1207 1213
3. R.N. Kaplan, R.D. Riba, S. Zacharoulis, A.H. Bramley, L. Vincent, C. Costa, D.D. MacDonald, D.K. Jin, K. Shido, S.A. Kerns, Z. Zhu, D. Hicklin, Y. Wu, J.L. Port, N. Altorki, E.R. Port, D. Ruggero, S.V. Shmelkov, K.K. Jensen, S. Rafii, and D. Lyden VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche Nature 438 2005 820 827
4. C. Fischer, M. Mazzone, B. Jonckx, and P. Carmeliet FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat Rev Cancer 8 2008 942 956
5. P. Carmeliet, V. Ferreira, G. Breier, S. Pollefeyt, L. Kieckens, M. Gertsenstein, M. Fahrig, A. Vandenhoeck, K. Harpal, C. Eberhardt, C. Declercq, J. Pawling, L. Moons, D. Collen, W. Risau, and A. Nagy Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele Nature 380 1996 435 439
6. M. Kanda, S. Nomoto, Y. Nishikawa, H. Sugimoto, N. Kanazumi, S. Takeda, and A. Nakao Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters J Surg Oncol 98 2008 190 196
7. S. Shintani, T. Ishikawa, T. Nonaka, C. Li, K. Nakashiro, D.T. Wong, and H. Hamakawa Growth-regulated oncogene-1 expression is associated with angiogenesis and lymph node metastasis in human oral cancer Oncology 66 2004 316 322
8. M. Bry, R. Kivela, T. Holopainen, A. Anisimov, T. Tammela, J. Soronen, J. Silvola, A. Saraste, M. Jeltsch, P. Korpisalo, P. Carmeliet, K.B. Lemstrom, M. Shibuya, S. Yla-Herttuala, L. Alhonen, E. Mervaala, L.C. Andersson, J. Knuuti, and K. Alitalo Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation Circulation 122 2010 1725 1733
9. S.C. Wei, P.N. Tsao, S.C. Yu, C.T. Shun, J.J. Tsai-Wu, C.H. Wu, Y.N. Su, F.J. Hsieh, and J.M. Wong Placenta growth factor expression is correlated with survival of patients with colorectal cancer Gut 54 2005 666 672
10. C. Parr, G. Watkins, M. Boulton, J. Cai, and W.G. Jiang Placenta growth factor is over-expressed and has prognostic value in human breast cancer Eur J Cancer 41 2005 2819 2827
11. C. Fischer, B. Jonckx, M. Mazzone, S. Zacchigna, S. Loges, L. Pattarini, E. Chorianopoulos, L. Liesenborghs, M. Koch, M. De Mol, M. Autiero, S. Wyns, S. Plaisance, L. Moons, N. van Rooijen, M. Giacca, J.M. Stassen, M. Dewerchin, D. Collen, and P. Carmeliet Anti-PlGF inhibits growth of VEGF(R)-inhibitor- resistant tumors without affecting healthy vessels Cell 131 2007 463 475
12. S. Hiratsuka, O. Minowa, J. Kuno, T. Noda, and M. Shibuya Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice Proc Natl Acad Sci USA 95 1998 9349 9354
13. J.B. Kearney, N.C. Kappas, C. Ellerstrom, F.W. DiPaola, and V.L. Bautch The VEGF receptor flt-1 (VEGFR-1) is a positive modulator of vascular sprout formation and branching morphogenesis Blood 103 2004 4527 4535
14. D.M. Roberts, J.B. Kearney, J.H. Johnson, M.P. Rosenberg, R. Kumar, and V.L. Bautch The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation Am J Pathol 164 2004 1531 1535
15. M. Jinnin, D. Medici, L. Park, N. Limaye, Y. Liu, E. Boscolo, J. Bischoff, M. Vikkula, E. Boye, and B.R. Olsen Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma Nat Med 14 2008 1236 1246
16. D.G. Bae, T.D. Kim, G. Li, W.H. Yoon, and C.B. Chae Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis Clin Cancer Res 11 2005 2651 2661
17. A. Luttun, M. Tjwa, L. Moons, Y. Wu, A. Angelillo-Scherrer, F. Liao, J.A. Nagy, A. Hooper, J. Priller, B. De Klerck, V. Compernolle, E. Daci, P. Bohlen, M. Dewerchin, J.M. Herbert, R. Fava, P. Matthys, G. Carmeliet, D. Collen, H.F. Dvorak, D.J. Hicklin, and P. Carmeliet Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 Nat Med 8 2002 831 840
18. M. Autiero, J. Waltenberger, D. Communi, A. Kranz, L. Moons, D. Lambrechts, J. Kroll, S. Plaisance, M. De Mol, F. Bono, S. Kliche, G. Fellbrich, K. Ballmer-Hofer, D. Maglione, U. Mayr-Beyrle, M. Dewerchin, S. Dombrowski, D. Stanimirovic, P. Van Hummelen, C. Dehio, D.J. Hicklin, G. Persico, J.M. Herbert, M. Shibuya, D. Collen, E.M. Conway, and P. Carmeliet Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 Nat Med 9 2003 936 943
19. J. Kami, K. Muranaka, Y. Yanagi, R. Obata, Y. Tamaki, and M. Shibuya Inhibition of choroidal neovascularization by blocking vascular endothelial growth factor receptor tyrosine kinase Jpn J Ophthalmol 52 2008 91 98
20. J.B. Mulliken Cutaneous vascular anomalies Semin Vasc Surg 6 1993 204 218
21. L.C. Chang, A.N. Haggstrom, B.A. Drolet, E. Baselga, S.L. Chamlin, M.C. Garzon, K.A. Horii, A.W. Lucky, A.J. Mancini, D.W. Metry, A.J. Nopper, and I.J. Frieden Growth characteristics of infantile hemangiomas: implications for management Pediatrics 122 2008 360 367
22. A. Picard, E. Boscolo, Z.A. Khan, T.C. Bartch, J.B. Mulliken, M.P. Vazquez, and J. Bischoff IGF-2 and FLT-1/VEGF-R1 mRNA levels reveal distinctions and similarities between congenital and common infantile hemangioma Pediatr Res 63 2008 263 267
23. S. Greenberger, E. Boscolo, I. Adini, J.B. Mulliken, and J. Bischoff Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells N Engl J Med 362 2010 1005 1013
24. Z.A. Khan, E. Boscolo, A. Picard, S. Psutka, J.M. Melero-Martin, T.C. Bartch, J.B. Mulliken, and J. Bischoff Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice J Clin Invest 118 2008 2592 2599
25. Z.A. Khan, J.M. Melero-Martin, X. Wu, S. Paruchuri, E. Boscolo, J.B. Mulliken, and J. Bischoff Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin Blood 108 2006 915 921
26. J.M. Wood, G. Bold, E. Buchdunger, R. Cozens, S. Ferrari, J. Frei, F. Hofmann, J. Mestan, H. Mett, T. O'Reilly, E. Persohn, J. Rosel, C. Schnell, D. Stover, A. Theuer, H. Towbin, F. Wenger, K. Woods-Cook, A. Menrad, G. Siemeister, M. Schirner, K.H. Thierauch, M.R. Schneider, J. Drevs, G. Martiny-Baron, and F. Totzke PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration Cancer Res 60 2000 2178 2189
27. Y. Yu, J.D. Hulmes, M.T. Herley, R.G. Whitney, J.W. Crabb, and J.D. Sato Direct identification of a major autophosphorylation site on vascular endothelial growth factor receptor Flt-1 that mediates phosphatidylinositol 3′-kinase binding Biochem J 358 2001 465 472
28. G. Bold, J. Frei, P. Furet, P. Manley, J. Bruggen, R. Cozens, S. Ferrari, F. Hofmann, G. Martiny-Baron, J. Mestan, T. Meyer, and J. Wood CGP 79787D (PTK787/ZK22584) CGP 84738, NVP-AAC789, NVP-AAD777 and related 1-anilino-(4-pyridylmethyl)phthalazines as inhibitors of VEGF- and bFGF-induced angiogenesis Drugs Future 27 2002 43 55
29. E. Boscolo, and J. Bischoff Vasculogenesis in infantile hemangioma Angiogenesis 12 2009 197 207
30. A.H. Yin, S. Miraglia, E.D. Zanjani, G. Almeida-Porada, M. Ogawa, A.G. Leary, J. Olweus, J. Kearney, and D.W. Buck AC133, a novel marker for human hematopoietic stem and progenitor cells Blood 90 1997 5002 5012
31. R. Wang, K. Chadalavada, J. Wilshire, U. Kowalik, K.E. Hovinga, A. Geber, B. Fligelman, M. Leversha, C. Brennan, and V. Tabar Glioblastoma stem-like cells give rise to tumour endothelium Nature 468 2010 824 838
32. L. Ricci-Vitiani, R. Pallini, M. Biffoni, M. Todaro, G. Invernici, T. Cenci, G. Maira, E.A. Parati, G. Stassi, L.M. Larocca, and R. De Maria Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells Nature 468 2010 829 833
33. J. Xu, X. Liu, Y. Jiang, L. Chu, H. Hao, Z. Liua, C. Verfaillie, J. Zweier, K. Gupta, and Z. Liu MAPK/ERK signalling mediates VEGF-induced bone marrow stem cell differentiation into endothelial cell J Cell Mol Med 12 2008 2395 2406
34. D. James, H.S. Nam, M. Seandel, D. Nolan, T. Janovitz, M. Tomishima, L. Studer, G. Lee, D. Lyden, R. Benezra, N. Zaninovic, Z. Rosenwaks, S.Y. Rabbany, and S. Rafii Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFbeta inhibition is Id1 dependent Nature Biotechnol 28 2010 161 166
35. H. Sase, T. Watabe, K. Kawasaki, K. Miyazono, and K. Miyazawa VEGFR2-PLCgamma1 axis is essential for endothelial specification of VEGFR2+ vascular progenitor cells J Cell Sci 122 2009 3303 3311
36. K. Kawasaki, T. Watabe, H. Sase, M. Hirashima, H. Koide, Y. Morishita, K. Yuki, T. Sasaoka, T. Suda, M. Katsuki, K. Miyazono, and K. Miyazawa Ras signaling directs endothelial specification of VEGFR2+ vascular progenitor cells J Cell Biol 181 2008 131 141
37. A. Gualandris, A. Noghero, M. Geuna, M. Arese, D. Valdembri, G. Serini, and F. Bussolino Microenvironment drives the endothelial or neural fate of differentiating embryonic stem cells coexpressing neuropilin-1 and Flk-1 FASEB J 23 2009 68 78
38. K. Yamamizu, K. Kawasaki, S. Katayama, T. Watabe, and J.K. Yamashita Enhancement of vascular progenitor potential by protein kinase A through dual induction of Flk-1 and Neuropilin-1 Blood 114 2009 3707 3716
39. M. Shibuya, and L. Claesson-Welsh Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis Exp Cell Res 312 2006 549 560
40. G. Di Cristo, N. Berardi, L. Cancedda, T. Pizzorusso, E. Putignano, G.M. Ratto, and L. Maffei Requirement of ERK activation for visual cortical plasticity Science 292 2001 2337 2340
41. M.P. Stavridis, J.S. Lunn, B.J. Collins, and K.G. Storey A discrete period of FGF-induced Erk1/2 signalling is required for vertebrate neural specification Development 134 2007 2889 2894
42. J. Lu, J. Zhao, K. Liu, H. Yang, Y. Huang, Z. Qin, R. Bai, P. Li, J. Ma, W. Yan, M. Zhao, and Z. Dong MAPK/ERK1/2 signaling mediates endothelial-like differentiation of immature DCs in the microenvironment of esophageal squamous cell carcinoma Cell Mol Life Sci 67 2010 2091 2106
43. S. Cowley, H. Paterson, P. Kemp, and C.J. Marshall Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells Cell 77 1994 841 852